Gsk (GSK) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)

Updated Oct 16, 2026, 4:00 PM ET

What changed since yesterday

GSK rises 1.0% to $49.51, 3 up days in a row. Closed at $49.51, +1.00% vs the prior close of $49.02. Day range $49.44–$49.97, opened at $49.62.

Last close$49.51+1.00%

Day range49.44–49.97

Open49.62

Volume6.92M

52-week range42.85–61.70

Avg volume (20d)5.53M

GSK daily analysis — what happened

A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.

Oct 16, 2026 — GSK rises 1.0% to $49.51, 3 up days in a row

Closed at $49.51, +1.00% vs the prior close of $49.02. Day range $49.44–$49.97, opened at $49.62.
Volume was 6.92M shares, 1.8x its 50-day average of 3.87M.
Price is -0.3% vs its 50-day average ($49.66) and -5.4% vs its 200-day average ($52.34).
52-week range $42.85–$61.70; today's close sits at 35% of that range, 19.8% below the 52-week high.
That makes 3 straight gains.

Oct 15, 2026 — GSK rises 2.4% to $49.02

Closed at $49.02, +2.40% vs the prior close of $47.87. Day range $48.98–$49.84, opened at $49.18.
Volume was 6.14M shares, 1.6x its 50-day average of 3.80M.
Price is -1.4% vs its 50-day average ($49.72) and -6.3% vs its 200-day average ($52.34).
52-week range $42.85–$61.70; today's close sits at 33% of that range, 20.6% below the 52-week high.
SEC filings that day: 6-K.

Oct 14, 2026 — GSK jumps 3.5% to $47.87 on 1.9x normal volume

Closed at $47.87, +3.46% vs the prior close of $46.27. Day range $46.55–$47.98, opened at $46.63.
Volume was 7.09M shares, 1.9x its 50-day average of 3.75M — unusually heavy trading.
Price is -3.8% vs its 50-day average ($49.76) and -8.5% vs its 200-day average ($52.34).
52-week range $42.85–$61.70; today's close sits at 27% of that range, 22.4% below the 52-week high.
SEC filings that day: 6-K.

Oct 13, 2026 — GSK dips 1.4% to $46.27, a 6-month low

Closed at $46.27, -1.39% vs the prior close of $46.92. Day range $46.11–$47.15, opened at $47.09.
Volume was 5.76M shares, 1.5x its 50-day average of 3.73M.
Price is -7.2% vs its 50-day average ($49.84) and -11.6% vs its 200-day average ($52.35).
52-week range $42.85–$61.70; today's close sits at 18% of that range, 25.0% below the 52-week high.
SEC filings that day: 6-K, 6-K.

Oct 12, 2026 — GSK rises 0.9% to $46.92 on 2.9x normal volume

Closed at $46.92, +0.90% vs the prior close of $46.50. Day range $46.31–$47.09, opened at $46.70.
Volume was 10.35M shares, 2.9x its 50-day average of 3.60M — unusually heavy trading.
Price is -6.1% vs its 50-day average ($49.94) and -10.4% vs its 200-day average ($52.36).
52-week range $42.85–$61.70; today's close sits at 22% of that range, 24.0% below the 52-week high.

Oct 9, 2026 — GSK ends flat (-0.1%) to $46.50, a 6-month low on 2.4x normal volume

Closed at $46.50, -0.09% vs the prior close of $46.54. Day range $46.27–$46.82, opened at $46.61.
Volume was 8.54M shares, 2.4x its 50-day average of 3.55M — unusually heavy trading.
Price is -7.1% vs its 50-day average ($50.04) and -11.2% vs its 200-day average ($52.37).
52-week range $42.85–$61.70; today's close sits at 19% of that range, 24.6% below the 52-week high.

Oct 8, 2026 — GSK dips 1.0% to $46.54, a 6-month low on 2.2x normal volume

Closed at $46.54, -1.02% vs the prior close of $47.02. Day range $45.83–$46.70, opened at $46.40.
Volume was 7.73M shares, 2.2x its 50-day average of 3.52M — unusually heavy trading.
Price is -7.2% vs its 50-day average ($50.15) and -11.2% vs its 200-day average ($52.38).
52-week range $42.85–$61.70; today's close sits at 20% of that range, 24.6% below the 52-week high.
SEC filings that day: 6-K.

Oct 7, 2026 — GSK rises 0.9% to $47.02

Closed at $47.02, +0.90% vs the prior close of $46.60. Day range $46.69–$47.41, opened at $46.92.
Volume was 5.85M shares, 1.6x its 50-day average of 3.57M.
Price is -6.5% vs its 50-day average ($50.28) and -10.3% vs its 200-day average ($52.39).
52-week range $42.85–$61.70; today's close sits at 22% of that range, 23.8% below the 52-week high.

Oct 6, 2026 — GSK ends flat (+0.1%) to $46.60 on 1.9x normal volume

Closed at $46.60, +0.11% vs the prior close of $46.55. Day range $46.18–$47.01, opened at $46.96.
Volume was 6.81M shares, 1.9x its 50-day average of 3.54M — unusually heavy trading.
Price is -7.6% vs its 50-day average ($50.42) and -11.1% vs its 200-day average ($52.40).
52-week range $42.85–$61.70; today's close sits at 20% of that range, 24.5% below the 52-week high.
SEC filings that day: 6-K.

Oct 5, 2026 — GSK dips 1.0% to $46.55, a 6-month low, 5 down days in a row

Closed at $46.55, -1.02% vs the prior close of $47.03. Day range $46.33–$46.89, opened at $46.73.
Volume was 3.48M shares, 1.0x its 50-day average of 3.59M.
Price is -7.9% vs its 50-day average ($50.52) and -11.2% vs its 200-day average ($52.41).
52-week range $42.85–$61.70; today's close sits at 20% of that range, 24.6% below the 52-week high.
That makes 5 straight losses.

Oct 2, 2026 — GSK dips 0.3% to $47.03, a 6-month low, 4 down days in a row

Closed at $47.03, -0.32% vs the prior close of $47.18. Day range $46.84–$47.16, opened at $47.08.
Volume was 5.39M shares, 1.5x its 50-day average of 3.57M.
Price is -7.1% vs its 50-day average ($50.62) and -10.3% vs its 200-day average ($52.42).
52-week range $42.85–$61.70; today's close sits at 22% of that range, 23.8% below the 52-week high.
That makes 4 straight losses.

Every SEC filing by or about GSK in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Oct 15, 2026 · Form 6-K — Report from a foreign company (6-K)